Filter
722
Text search:
candidates
Featured
Recommendations
66
New Publications
174
Language
Document type
No document type
364
Studies & Reports
143
Guidelines
86
Manuals
34
Fact sheets
34
Strategic & Response Plan
25
Resource Platforms
12
Training Material
10
Videos
6
Situation Updates
4
Online Courses
3
Brochures
1
Countries / Regions
India
45
Global
29
Liberia
18
South Africa
17
Nepal
16
Zambia
16
Kenya
14
Sierra Leone
12
Malawi
12
Western and Central Europe
12
Ethiopia
11
Latin America and the Carribbean
11
Africa
11
Nigeria
10
Tanzania
10
West and Central Africa
10
Myanmar / Burma
9
East and Southern Africa
9
Uganda
8
Bangladesh
8
Middle East and North Africa
8
Russia
8
Philippines
7
Syria
7
Rwanda
7
Ghana
6
Haiti
6
Germany
6
Eastern Europe
6
Guinea
5
Congo, Democratic Republic of
5
Zimbabwe
5
Cambodia
5
China
5
Namibia
5
Senegal
4
USA
4
South Sudan
4
Ukraine
4
Brazil
3
Botswana
3
Asia
3
Turkey
2
Thailand
2
Indonesia
2
Mozambique
2
Benin
2
Central African Republic
2
Peru
2
North Macedonia
2
Colombia
2
Madagascar
2
Lesotho
2
Georgia
2
Portugal
2
Burkina Faso
1
Morocco
1
Cameroon
1
Jordan
1
Afghanistan
1
Lebanon
1
Papua New Guinea
1
Argentina
1
Switzerland
1
Hungary
1
Mexico
1
Eastern Europe and Central Asia
1
Paraguay
1
Timor Leste/ East Timor
1
Tajikistan
1
Lithuania
1
Kyrgyzstan
1
Kazakhstan
1
Vietnam
1
Jamaica
1
France
1
United Kingdom
1
Norway
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
257
Clinical Guidelines
60
Public Health
29
Key Resources
26
Women & Child Health
21
Capacity Building
8
Pharmacy & Technologies
4
Annual Report MEDBOX
1
Toolboxes
COVID-19
111
TB
40
Mental Health
39
NTDs
35
Disability
33
HIV
31
Caregiver
27
Ebola & Marburg
25
AMR
16
Refugee
14
Rapid Response
12
Malaria
12
Conflict
9
Natural Hazards
9
Health Financing Toolbox
9
NCDs
8
Global Health Education
7
Planetary Health
7
Zika
6
Pharmacy
6
2.0 Rapid Response
5
Polio
4
Social Ethics
4
Cholera
3
Typhoon
3
Cet article fait partie d’une série d’explications à propos de la mise au point et de la distribution des vaccins.
Available in different languages
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
Vaccines are supported by decades of medical research.
...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc
...
Comment The Lancet Volume 397, ISSUE 10269, P72-74, January 09, 2021
Published:December 08, 2020DOI:https://doi.org/10.1016/S0140-6736(20)32623-4
As of January 20, 2021 the Covid-19 - living NMA initiative collected 150 RCTs and 36 non-randomised studies of vaccines from the ICTRP. 93 of these trials are recruiting patients.
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto
...
orientations provisoires, première publication: 10 février 2021, mise à jour : 21 avril 2021, dernière mise à jour : 30 juillet 2021
временное руководство. Первый выпуск: 10 февраля 2021 г. Обновлено: 21 апреля 2021 г. Последнее обновление 30 июля 2021г.
Cet article fait partie d’une série d’explications à propos de la mise au point et de la distribution des vaccins.
Available in English, French, Spanisch, Arabic, Chinese and Russian
How COVID-19 mRNA Vaccines Work
recommended
COVID-19 mRNA vaccines deliver directions to make a protein that educates our immune system, so it will neutralize the virus in future encounters. The mRNA-containing lipid particles are taken up by specialized immune system cells
This quick guide offers basic information about COVID-19, the Sinovac-CoronaVac COVID-19 vaccine and what to
expect following vaccination: ...
This article is part four in a series of explainers on vaccine development and distribution.
Part one focused on how vaccines work to protect our bodies from disease-carrying germs.
Part two focused on the ingredients in a vaccine and the three clinical trial phases.
Part three focused on the ste
...
Adaptable guidance, tools, trainings, and advocacy materials are being developed to support countries in preparing for COVID-19 vaccination. Please visit this page regularly for updates.
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) ir
...